Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
The epithelial-mesenchymal transition (EMT) has been implicated in stem cell properties and therapeutic resistance in cancer. Here, the authors show organoids derived from mesenchymal breast cancers exhibit a spikey structure which can be reverted and exploited for screening drugs that reverse EMT.
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4bf1f86424d4458c89d66da69cca86c8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4bf1f86424d4458c89d66da69cca86c8 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4bf1f86424d4458c89d66da69cca86c82021-12-02T17:01:29ZMorphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition10.1038/s41467-021-24545-32041-1723https://doaj.org/article/4bf1f86424d4458c89d66da69cca86c82021-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-24545-3https://doaj.org/toc/2041-1723The epithelial-mesenchymal transition (EMT) has been implicated in stem cell properties and therapeutic resistance in cancer. Here, the authors show organoids derived from mesenchymal breast cancers exhibit a spikey structure which can be reverted and exploited for screening drugs that reverse EMT.Na ZhaoReid T. PowellXueying YuanGoeun BaeKevin P. RoartyFabio StossiMartina StrempflMichael J. ToneffHannah L. JohnsonSendurai A. ManiPhilip JonesClifford C. StephanJeffrey M. RosenNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-13 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Na Zhao Reid T. Powell Xueying Yuan Goeun Bae Kevin P. Roarty Fabio Stossi Martina Strempfl Michael J. Toneff Hannah L. Johnson Sendurai A. Mani Philip Jones Clifford C. Stephan Jeffrey M. Rosen Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition |
description |
The epithelial-mesenchymal transition (EMT) has been implicated in stem cell properties and therapeutic resistance in cancer. Here, the authors show organoids derived from mesenchymal breast cancers exhibit a spikey structure which can be reverted and exploited for screening drugs that reverse EMT. |
format |
article |
author |
Na Zhao Reid T. Powell Xueying Yuan Goeun Bae Kevin P. Roarty Fabio Stossi Martina Strempfl Michael J. Toneff Hannah L. Johnson Sendurai A. Mani Philip Jones Clifford C. Stephan Jeffrey M. Rosen |
author_facet |
Na Zhao Reid T. Powell Xueying Yuan Goeun Bae Kevin P. Roarty Fabio Stossi Martina Strempfl Michael J. Toneff Hannah L. Johnson Sendurai A. Mani Philip Jones Clifford C. Stephan Jeffrey M. Rosen |
author_sort |
Na Zhao |
title |
Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition |
title_short |
Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition |
title_full |
Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition |
title_fullStr |
Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition |
title_full_unstemmed |
Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition |
title_sort |
morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/4bf1f86424d4458c89d66da69cca86c8 |
work_keys_str_mv |
AT nazhao morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition AT reidtpowell morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition AT xueyingyuan morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition AT goeunbae morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition AT kevinproarty morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition AT fabiostossi morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition AT martinastrempfl morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition AT michaeljtoneff morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition AT hannahljohnson morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition AT senduraiamani morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition AT philipjones morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition AT cliffordcstephan morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition AT jeffreymrosen morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition |
_version_ |
1718382080191102976 |